Skip to main content
Livermore
Livermore
ZHEN

Jarislowsky, Fraser Ltd

SEC CIK
0001123778
Latest filing
Oct 21, 2025

ABT holding history

Abbott Laboratories in every 13F filed by Jarislowsky, Fraser Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q3 2025 holdings

Shares (Q3 2025)
2,158,089
Value
$289.1M
% of portfolio
1.6%
Quarters held
19
Since Q1 2021
Holdings of ABT by Jarislowsky, Fraser Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20252,158,089$289.1M1.6%−37,740−1.7%ReducedHolders
Q2 20252,195,829$298.7M1.7%+26,112+1.2%AddedHolders
Q1 20252,169,717$287.8M1.8%−92,674−4.1%ReducedHolders
Q4 20242,262,391$254.0M1.5%−114,939−4.8%ReducedHolders
Q3 20242,377,330$271.0M1.5%+172,772+7.8%AddedHolders
Q2 20242,204,558$229.1M1.4%+124,685+6.0%AddedHolders
Q1 20242,079,873$236.4M1.4%−42,532−2.0%ReducedHolders
Q4 20232,122,405$233.6M1.4%−58,487−2.7%ReducedHolders
Q3 20232,180,892$211.2M1.4%−17,300−0.8%ReducedHolders
Q2 20232,198,192$239.6M1.4%−59,999−2.7%ReducedHolders
Q1 20232,258,191$228.7M1.4%−19,754−0.9%ReducedHolders
Q4 20222,277,945$250.1M1.6%−23,580−1.0%ReducedHolders
Q3 20222,301,525$222.7M1.5%−5,430−0.2%ReducedHolders
Q2 20222,306,955$250.7M1.6%−46,122−2.0%ReducedHolders
Q1 20222,353,077$278.5M1.5%+101,994+4.5%AddedHolders
Q4 20212,251,083$316.8M1.5%−20,723−0.9%ReducedHolders
Q3 20212,271,806$268.4M1.3%−24,981−1.1%ReducedHolders
Q2 20212,296,787$266.3M1.2%+19,907+0.9%AddedHolders
Q1 20212,276,880$272.9M1.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.